United States Healthcare Providers & Services

Encompass Health Corporation (EHC)

Encompass Health Corporation experienced significant selling activity recently, with executives offloading over $26 million in net value. Key leadership, including the CEO and CFO, executed multiple divestments. These transactions occurred amid a 9.5% stock price increase over the last quarter, following positive results financiers where the firm outperformed earnings expectations by nearly 11%.
Ticker: EHC Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Encompass Health Corporation. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
Darby John Patrick EVP, Gen Counsel & Secretary Officer
Transaction date
Sale
Price
358.67
Quantity 2,754 +26.1%
Value US$2,291,086
2.0
Price Andrew L Chief Accounting Officer Officer
Transaction date
Sale
Price
394.37
Quantity 58,041 -1.5%
Value US$784,935
1.9
John Patrick Darby Officer Officer
Transaction date
Proposed sale
Price
449.82
Quantity 47,568
Value US$4,063,075
1.9
Darby John Patrick EVP, Gen Counsel & Secretary Officer
Transaction date
Sale
Price
125.95
Quantity 8,906 -10.6%
Value US$1,121,711
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
125.38
Quantity 18,869 -27.2%
Value US$2,365,795
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
126.06
Quantity 1,579 -0.6%
Value US$199,049
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
125.46
Quantity 171,569 -38.9%
Value US$21,525,047
3.4
Mark Tarr Officer Officer
Transaction date
Proposed sale
Price
125.45
Quantity 173,148
Value US$21,722,175
1.9
John Patrick Darby Officer Officer
Transaction date
Proposed sale
Price
125.95
Quantity 8,906
Value US$1,121,701
2.9
Douglas Coltharp Officer Officer
Transaction date
Proposed sale
Price
125.38
Quantity 18,869
Value US$2,365,701
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
107.28
Quantity 1 -0.0%
Value US$107
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
106.83
Quantity 27,693 -28.5%
Value US$2,958,443
2.9
Douglas Edward Coltharp Officer Officer
Transaction date
Proposed sale
Price
106.83
Quantity 27,694
Value US$2,958,629
3.0
Tuer Patrick William EVP, Chief Operating Officer Officer
Transaction date
Sale
Price
104.56
Quantity 682 -2.7%
Value US$71,310
3.0
Patrick Tuer Officer Officer
Transaction date
Proposed sale
Price
104.56
Quantity 682
Value US$71,312
1.7
Fay Edmund Sr. Vice Pres. and Treasurer Officer
Transaction date
Sale
Price
107.00
Quantity 11,937 -11.8%
Value US$1,277,259
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
113.58
Quantity 213 -0.1%
Value US$24,193
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
113.09
Quantity 87,745 -18.9%
Value US$9,923,082
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
111.89
Quantity 6,057 -1.3%
Value US$677,718
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
110.92
Quantity 10,954 -2.3%
Value US$1,215,018
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
110.07
Quantity 15,584 -3.1%
Value US$1,715,331
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
108.80
Quantity 13,231 -2.6%
Value US$1,439,533
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
108.03
Quantity 16,216 -3.1%
Value US$1,751,814
3.4
Mark Tarr Officer Officer
Transaction date
Proposed sale
Price
111.59
Quantity 150,000
Value US$16,738,961
3.0
Tuer Patrick William EVP, Chief Operating Officer Officer
Transaction date
Sale
Price
107.62
Quantity 2,804 -14.9%
Value US$301,766
3.0
Patrick Tuer Officer Officer
Transaction date
Proposed sale
Price
107.62
Quantity 2,804
Value US$301,755
3.0
Patrick Tuer Officer Officer
Transaction date
Proposed sale
Price
123.59
Quantity 1,020
Value US$126,062
3.0
Tuer Patrick William EVP, Chief Operating Officer Officer
Transaction date
Sale
Price
123.59
Quantity 1,020 -5.1%
Value US$126,062
3.4
Mark Tarr Officer Officer
Transaction date
Proposed sale
Price
121.50
Quantity 118,384
Value US$14,383,656
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
121.53
Quantity 118,290 -18.3%
Value US$14,375,784
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
120.94
Quantity 94 -0.0%
Value US$11,368
2.3
Charbonneau Elissa Joy Chief Medical Officer Officer
Transaction date
Sale
Price
116.61
Quantity 4,279 -26.4%
Value US$498,974
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
116.36
Quantity 3,934 -6.1%
Value US$457,760
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
115.51
Quantity 13,402 -17.3%
Value US$1,548,065
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
114.78
Quantity 26,239 -25.3%
Value US$3,011,712
1.9
Darby John Patrick EVP, Gen Counsel & Secretary Officer
Transaction date
Sale
Price
114.79
Quantity 10,000 -11.1%
Value US$1,147,900
1.9
John Patrick Darby Officer Officer
Transaction date
Proposed sale
Price
114.79
Quantity 14,858
Value US$1,705,539
2.9
Douglas Edward Coltharp Officer Officer
Transaction date
Proposed sale
Price
115.15
Quantity 43,575
Value US$5,017,565
2.0
Price Andrew L Chief Accounting Officer Officer
Transaction date
Sale
Price
98.29
Quantity 5,042 -6.8%
Value US$495,578
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
87.03
Quantity 98 -0.1%
Value US$8,529
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
86.33
Quantity 12,162 -8.2%
Value US$1,049,945
2.9
Douglas Coltharp Officer Officer
Transaction date
Proposed sale
Price
86.34
Quantity 12,260
Value US$1,058,520
2.3
Charbonneau Elissa Joy Chief Medical Officer Officer
Transaction date
Sale
Price
85.02
Quantity 10,000 -35.0%
Value US$850,200
2.3
Charbonneau Elissa Joy Chief Medical Officer Officer
Transaction date
Sale
Price
85.02
Quantity 10,000 -35.0%
Value US$850,200
2.2
CHIDSEY JOHN Officer Officer
Transaction date
Proposed sale
Price
85.39
Quantity 29,500
Value US$2,518,936
1.9
Darby John Patrick EVP, Gen Counsel & Secretary Officer
Transaction date
Sale
Price
83.94
Quantity 14,543 -14.6%
Value US$1,220,739
1.9
Darby John Patrick EVP, Gen Counsel & Secretary Officer
Transaction date
Sale
Price
83.94
Quantity 14,543 -14.6%
Value US$1,220,739
1.9
John Patrick Darby Officer Officer
Transaction date
Proposed sale
Price
84.20
Quantity 14,543
Value US$1,224,520
3.0
CARMICHAEL GREG D Non-Executive Director
Transaction date
Purchase
Price
83.73
Quantity 2,000 +13.3%
Value US$167,460
3.0
CARMICHAEL GREG D Non-Executive Director
Transaction date
Purchase
Price
83.73
Quantity 2,000 +13.3%
Value US$167,460
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
83.27
Quantity 44,976 -7.5%
Value US$3,745,152
3.4
Mark J Tarr CEO
Transaction date
Proposed sale
Price
83.64
Quantity 44,976
Value US$3,761,792
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
63.39
Quantity 11,215 -8.8%
Value US$710,919
2.9
Douglas Edward Coltharp Officer Officer
Transaction date
Proposed sale
Price
63.39
Quantity 11,215
Value US$710,914
2.3
Charbonneau Elissa Joy Chief Medical Officer Officer
Transaction date
Sale
Price
69.58
Quantity 8,294 -26.4%
Value US$577,097
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
71.06
Quantity 25,330 -4.8%
Value US$1,799,950
3.4
Mark J. Tarr Officer Officer
Transaction date
Proposed sale
Price
71.06
Quantity 25,330
Value US$1,799,945
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
60.78
Quantity 17,895 -25.2%
Value US$1,087,658
3.0
CARMICHAEL GREG D Non-Executive Director
Transaction date
Purchase
Price
54.67
Quantity 1,830 +21.0%
Value US$100,046
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
53.25
Quantity 20,449 -4.4%
Value US$1,088,909
3.1
O'Connor Kevin J. Non-Executive Director
Transaction date
Purchase
Price
66.48
Quantity 1,000 +41.1%
Value US$66,480
3.2
Williams Terrance Non-Executive Director
Transaction date
Purchase
Price
56.61
Quantity 354 +7.2%
Value US$20,040
2.0
Price Andrew L Chief Accounting Officer Officer
Transaction date
Sale
Price
81.40
Quantity 8,589 -11.9%
Value US$699,145
2.3
Charbonneau Elissa Joy Chief Medical Officer Officer
Transaction date
Planned sale
Price
75.22
Quantity 6,650 -24.8%
Value US$500,213
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
76.15
Quantity 490 -0.3%
Value US$37,314
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
75.73
Quantity 23,011 -12.7%
Value US$1,742,623
2.7
Jacobsmeyer Barbara Ann President, Inpatient Hospitals Officer
Transaction date
Sale
Price
64.73
Quantity 2,500 -5.3%
Value US$161,825
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
61.92
Quantity 26,132 -6.4%
Value US$1,618,093
1.8
CORRELL DONALD L Non-Executive Director
Transaction date
Sale
Price
59.04
Quantity 2,000 -2.8%
Value US$118,080
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
60.76
Quantity 8,083 +4.4%
Value US$491,123
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
59.95
Quantity 20,580 +12.6%
Value US$1,233,771
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
58.91
Quantity 41,607 +34.3%
Value US$2,451,068
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
58.09
Quantity 38,882 +47.1%
Value US$2,258,655
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
57.29
Quantity 10,738 +14.9%
Value US$615,180
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
56.44
Quantity 4,410 +6.5%
Value US$248,900
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-01 2026-08-31 S Sale
1.9
Darby John Patrick

EVP, Gen Counsel & Secretary

Officer
2,754 +26.1%
358.67
US$2,291,086 		2,754 +26.1% 358.67 US$2,291,086
2026-09-01 2026-08-31 S Sale
2.0
Price Andrew L

Chief Accounting Officer

Officer
58,041 -1.5%
394.37
US$784,935 		58,041 -1.5% 394.37 US$784,935
2026-08-31 2026-08-31 PrS Proposed sale
1.9
John Patrick Darby

Officer

Officer
47,568
449.82
US$4,063,075 		47,568 449.82 US$4,063,075
2026-08-11 2026-08-10 S Sale
1.9
Darby John Patrick

EVP, Gen Counsel & Secretary

Officer
8,906 -10.6%
125.95
US$1,121,711 		8,906 -10.6% 125.95 US$1,121,711
2026-08-11 2026-08-10 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
18,869 -27.2%
125.38
US$2,365,795 		18,869 -27.2% 125.38 US$2,365,795
2026-08-11 2026-08-10 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
1,579 -0.6%
126.06
US$199,049 		1,579 -0.6% 126.06 US$199,049
2026-08-11 2026-08-10 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
171,569 -38.9%
125.46
US$21,525,047 		171,569 -38.9% 125.46 US$21,525,047
2026-08-10 2026-08-10 PrS Proposed sale
3.4
Mark Tarr

Officer

Officer
173,148
125.45
US$21,722,175 		173,148 125.45 US$21,722,175
2026-08-10 2026-08-10 PrS Proposed sale
1.9
John Patrick Darby

Officer

Officer
8,906
125.95
US$1,121,701 		8,906 125.95 US$1,121,701
2026-08-10 2026-08-10 PrS Proposed sale
2.9
Douglas Coltharp

Officer

Officer
18,869
125.38
US$2,365,701 		18,869 125.38 US$2,365,701
2026-05-18 2026-05-15 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
1 -0.0%
107.28
US$107 		1 -0.0% 107.28 US$107
2026-05-18 2026-05-15 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
27,693 -28.5%
106.83
US$2,958,443 		27,693 -28.5% 106.83 US$2,958,443
2026-05-15 2026-05-15 PrS Proposed sale
2.9
Douglas Edward Coltharp

Officer

Officer
27,694
106.83
US$2,958,629 		27,694 106.83 US$2,958,629
2026-05-12 2026-05-11 S Sale
3.0
Tuer Patrick William

EVP, Chief Operating Officer

Officer
682 -2.7%
104.56
US$71,310 		682 -2.7% 104.56 US$71,310
2026-05-11 2026-05-11 PrS Proposed sale
3.0
Patrick Tuer

Officer

Officer
682
104.56
US$71,312 		682 104.56 US$71,312
2026-03-10 2026-03-09 S Sale
1.7
Fay Edmund

Sr. Vice Pres. and Treasurer

Officer
11,937 -11.8%
107.00
US$1,277,259 		11,937 -11.8% 107.00 US$1,277,259
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
213 -0.1%
113.58
US$24,193 		213 -0.1% 113.58 US$24,193
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
87,745 -18.9%
113.09
US$9,923,082 		87,745 -18.9% 113.09 US$9,923,082
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
6,057 -1.3%
111.89
US$677,718 		6,057 -1.3% 111.89 US$677,718
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
10,954 -2.3%
110.92
US$1,215,018 		10,954 -2.3% 110.92 US$1,215,018
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
15,584 -3.1%
110.07
US$1,715,331 		15,584 -3.1% 110.07 US$1,715,331
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
13,231 -2.6%
108.80
US$1,439,533 		13,231 -2.6% 108.80 US$1,439,533
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
16,216 -3.1%
108.03
US$1,751,814 		16,216 -3.1% 108.03 US$1,751,814
2026-02-11 2026-02-11 PrS Proposed sale
3.4
Mark Tarr

Officer

Officer
150,000
111.59
US$16,738,961 		150,000 111.59 US$16,738,961
2026-02-10 2026-02-10 S Sale
3.0
Tuer Patrick William

EVP, Chief Operating Officer

Officer
2,804 -14.9%
107.62
US$301,766 		2,804 -14.9% 107.62 US$301,766
2026-02-10 2026-02-10 PrS Proposed sale
3.0
Patrick Tuer

Officer

Officer
2,804
107.62
US$301,755 		2,804 107.62 US$301,755
2025-08-27 2025-08-27 PrS Proposed sale
3.0
Patrick Tuer

Officer

Officer
1,020
123.59
US$126,062 		1,020 123.59 US$126,062
2025-08-27 2025-08-27 S Sale
3.0
Tuer Patrick William

EVP, Chief Operating Officer

Officer
1,020 -5.1%
123.59
US$126,062 		1,020 -5.1% 123.59 US$126,062
2025-05-20 2025-05-20 PrS Proposed sale
3.4
Mark Tarr

Officer

Officer
118,384
121.50
US$14,383,656 		118,384 121.50 US$14,383,656
2025-05-20 2025-05-20 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
118,290 -18.3%
121.53
US$14,375,784 		118,290 -18.3% 121.53 US$14,375,784
2025-05-20 2025-05-20 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
94 -0.0%
120.94
US$11,368 		94 -0.0% 120.94 US$11,368
2025-05-07 2025-05-06 S Sale
2.3
Charbonneau Elissa Joy

Chief Medical Officer

Officer
4,279 -26.4%
116.61
US$498,974 		4,279 -26.4% 116.61 US$498,974
2025-04-30 2025-04-29 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
3,934 -6.1%
116.36
US$457,760 		3,934 -6.1% 116.36 US$457,760
2025-04-30 2025-04-29 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
13,402 -17.3%
115.51
US$1,548,065 		13,402 -17.3% 115.51 US$1,548,065
2025-04-30 2025-04-29 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
26,239 -25.3%
114.78
US$3,011,712 		26,239 -25.3% 114.78 US$3,011,712
2025-04-30 2025-04-29 S Sale
1.9
Darby John Patrick

EVP, Gen Counsel & Secretary

Officer
10,000 -11.1%
114.79
US$1,147,900 		10,000 -11.1% 114.79 US$1,147,900
2025-04-29 2025-04-29 PrS Proposed sale
1.9
John Patrick Darby

Officer

Officer
14,858
114.79
US$1,705,539 		14,858 114.79 US$1,705,539
2025-04-29 2025-04-29 PrS Proposed sale
2.9
Douglas Edward Coltharp

Officer

Officer
43,575
115.15
US$5,017,565 		43,575 115.15 US$5,017,565
2025-02-13 2025-02-13 S Sale
2.0
Price Andrew L

Chief Accounting Officer

Officer
5,042 -6.8%
98.29
US$495,578 		5,042 -6.8% 98.29 US$495,578
2024-08-14 2024-08-13 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
98 -0.1%
87.03
US$8,529 		98 -0.1% 87.03 US$8,529
2024-08-14 2024-08-13 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
12,162 -8.2%
86.33
US$1,049,945 		12,162 -8.2% 86.33 US$1,049,945
2024-08-13 2024-08-13 PrS Proposed sale
2.9
Douglas Coltharp

Officer

Officer
12,260
86.34
US$1,058,520 		12,260 86.34 US$1,058,520
2024-05-24 2024-05-24 S Sale
2.3
Charbonneau Elissa Joy

Chief Medical Officer

Officer
10,000 -35.0%
85.02
US$850,200 		10,000 -35.0% 85.02 US$850,200
2024-05-24 2024-05-24 S Sale
2.3
Charbonneau Elissa Joy

Chief Medical Officer

Officer
10,000 -35.0%
85.02
US$850,200 		10,000 -35.0% 85.02 US$850,200
2024-05-22 2024-05-22 PrS Proposed sale
2.2
CHIDSEY JOHN

Officer

Officer
29,500
85.39
US$2,518,936 		29,500 85.39 US$2,518,936
2024-05-07 2024-05-06 S Sale
1.9
Darby John Patrick

EVP, Gen Counsel & Secretary

Officer
14,543 -14.6%
83.94
US$1,220,739 		14,543 -14.6% 83.94 US$1,220,739
2024-05-07 2024-05-06 S Sale
1.9
Darby John Patrick

EVP, Gen Counsel & Secretary

Officer
14,543 -14.6%
83.94
US$1,220,739 		14,543 -14.6% 83.94 US$1,220,739
2024-05-06 2024-05-06 PrS Proposed sale
1.9
John Patrick Darby

Officer

Officer
14,543
84.20
US$1,224,520 		14,543 84.20 US$1,224,520
2024-05-07 2024-05-03 B Purchase
3.0
CARMICHAEL GREG D
Non-Executive Director
2,000 +13.3%
83.73
US$167,460 		2,000 +13.3% 83.73 US$167,460
2024-05-07 2024-05-03 B Purchase
3.0
CARMICHAEL GREG D
Non-Executive Director
2,000 +13.3%
83.73
US$167,460 		2,000 +13.3% 83.73 US$167,460
2024-05-01 2024-04-30 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
44,976 -7.5%
83.27
US$3,745,152 		44,976 -7.5% 83.27 US$3,745,152
2024-04-30 2024-04-30 PrS Proposed sale
3.4
Mark J Tarr

CEO
44,976
83.64
US$3,761,792 		44,976 83.64 US$3,761,792
2023-11-14 2023-11-13 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
11,215 -8.8%
63.39
US$710,919 		11,215 -8.8% 63.39 US$710,919
2023-11-13 2023-11-13 PrS Proposed sale
2.9
Douglas Edward Coltharp

Officer

Officer
11,215
63.39
US$710,914 		11,215 63.39 US$710,914
2023-08-18 2023-08-17 S Sale
2.3
Charbonneau Elissa Joy

Chief Medical Officer

Officer
8,294 -26.4%
69.58
US$577,097 		8,294 -26.4% 69.58 US$577,097
2023-08-17 2023-08-16 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
25,330 -4.8%
71.06
US$1,799,950 		25,330 -4.8% 71.06 US$1,799,950
2023-08-16 2023-08-16 PrS Proposed sale
3.4
Mark J. Tarr

Officer

Officer
25,330
71.06
US$1,799,945 		25,330 71.06 US$1,799,945
2023-02-13 2023-02-10 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
17,895 -25.2%
60.78
US$1,087,658 		17,895 -25.2% 60.78 US$1,087,658
2022-11-01 2022-10-31 B Purchase
3.0
CARMICHAEL GREG D
Non-Executive Director
1,830 +21.0%
54.67
US$100,046 		1,830 +21.0% 54.67 US$100,046
2022-08-19 2022-08-17 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
20,449 -4.4%
53.25
US$1,088,909 		20,449 -4.4% 53.25 US$1,088,909
2022-05-09 2022-05-06 B Purchase
3.1
O'Connor Kevin J.
Non-Executive Director
1,000 +41.1%
66.48
US$66,480 		1,000 +41.1% 66.48 US$66,480
2021-12-02 2021-12-02 B Purchase
3.2
Williams Terrance
Non-Executive Director
354 +7.2%
56.61
US$20,040 		354 +7.2% 56.61 US$20,040
2021-03-09 2021-03-08 S Sale
2.0
Price Andrew L

Chief Accounting Officer

Officer
8,589 -11.9%
81.40
US$699,145 		8,589 -11.9% 81.40 US$699,145
2020-11-19 2020-11-17 PlS Planned sale
2.3
Charbonneau Elissa Joy

Chief Medical Officer

Officer
6,650 -24.8%
75.22
US$500,213 		6,650 -24.8% 75.22 US$500,213
2020-05-29 2020-05-28 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
490 -0.3%
76.15
US$37,314 		490 -0.3% 76.15 US$37,314
2020-05-29 2020-05-28 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
23,011 -12.7%
75.73
US$1,742,623 		23,011 -12.7% 75.73 US$1,742,623
2020-05-18 2020-05-15 S Sale
2.7
Jacobsmeyer Barbara Ann

President, Inpatient Hospitals

Officer
2,500 -5.3%
64.73
US$161,825 		2,500 -5.3% 64.73 US$161,825
2020-05-14 2020-05-14 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
26,132 -6.4%
61.92
US$1,618,093 		26,132 -6.4% 61.92 US$1,618,093
2020-03-16 2020-03-12 S Sale
1.8
CORRELL DONALD L
Non-Executive Director
2,000 -2.8%
59.04
US$118,080 		2,000 -2.8% 59.04 US$118,080
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
8,083 +4.4%
60.76
US$491,123 		8,083 +4.4% 60.76 US$491,123
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
20,580 +12.6%
59.95
US$1,233,771 		20,580 +12.6% 59.95 US$1,233,771
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
41,607 +34.3%
58.91
US$2,451,068 		41,607 +34.3% 58.91 US$2,451,068
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
38,882 +47.1%
58.09
US$2,258,655 		38,882 +47.1% 58.09 US$2,258,655
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
10,738 +14.9%
57.29
US$615,180 		10,738 +14.9% 57.29 US$615,180
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
4,410 +6.5%
56.44
US$248,900 		4,410 +6.5% 56.44 US$248,900

See older Encompass Health Corporation insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Encompass Health Corporation history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Encompass Health Corporation

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America